Le Lézard
Classified in: Health
Subjects: NPT, VET

Beyond Traditional Approaches: Blue Star Families' Innovative Solutions to Challenges in Military Life


WASHINGTON, July 25, 2023 /PRNewswire/ -- The military community faces a number of unique challenges, including frequent deployments, long separations, and the constant threat of danger. These challenges can take a toll on the mental and emotional health of service members and their families.

Blue Star Families is strengthening military families and preventing suicide through innovative solutions.

In recent years, Blue Star Families has been working to address these challenges by developing innovative, data-backed, evidence-informed solutions. One of their most successful programs is the Combat the Silence campaign, which aims to prevent military suicide by empowering the immediate network of a struggling service member or Veteran to provide support.

The Combat the Silence campaign is based on the idea that the best way to help someone who is struggling with mental health challenges is to provide them with a strong support network. This network can help to identify early signs of a crisis, provide emotional support, and connect the individual with professional help if needed.

The Combat the Silence campaign is unique in that it takes a proactive approach to suicide prevention. Instead of waiting for someone to reach out for help, the campaign empowers their immediate network to take action and provide support. This approach has been shown to be effective in reducing the risk of suicide, and it is a model that can be replicated in other settings.

In addition to the Combat the Silence campaign, Blue Star Families also offers a number of other programs that help to address the challenges faced by military families. These programs include:

Blue Star Families' innovative solutions are making a real difference in the lives of military families. By providing support, resources, and education, Blue Star Families is helping to strengthen military families and prevent suicide.

The Power of Collective Action

The Combat the Silence campaign is a powerful example of the power of collective action. By working together, we can make a real difference in the lives of military families and help to prevent suicide.

If you are interested in learning more about Blue Star Families or getting involved in their work, please visit their website at www.bluestarfam.org.

Together, we can combat the silence.

About Blue Star Families
Blue Star Families is the nation's largest community-based organization supporting military-connected families. Its research-driven approach builds strong communities through innovative solutions. For more information, click here.

SOURCE Blue Star Families


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: